Support Line: 0800 002 9002
General Enquiries: 01223 870008

News Archive

Featured

Santa In The City

Santa In The City

Starting at 7.00 pm by the Tate Modern, run the 4.3km festive fun run on either wednesday 6th or Thursday 7th ...
Santa In The City

Santa In The City

Starting at 7.00 pm by the Tate Modern, run the 4.3km festive fun run on either wednesday 6th or Thursday 7th ...
Get Involved, Fundraise For Kidney Cancer UK

Get Involved, Fundraise For Kidney Cancer UK

Webinar – TKI/Immunotherapy and side effect management

Webinar – TKI/Immunotherapy and side effect management

You are invited to join our next Living with Kidney Cancer Webinar on the 6th June at 6pm. The event is free and ...
Webinar – TKI/Immunotherapy and side effect management

Webinar – TKI/Immunotherapy and side effect management

Our Kidney Cancer Patient Survey 2022 Report

Our Kidney Cancer Patient Survey 2022 Report

Kidney cancer guidelines for doctors needed now In the week of Kidney Cancer Awareness Week 2023, Kidney ...
Kidney Cancer UK secure landmark kidney cancer NICE clinical guideline

Kidney Cancer UK secure landmark kidney cancer NICE clinical guideline

Kidney Cancer UK, the UK’s leading kidney cancer charity has, through its approach to NHS England, secured a ...
NHS gives GP teams direct access to tests to speed up cancer diagnosis

NHS gives GP teams direct access to tests to speed up cancer diagnosis

NHS Press Release (16th November 2022) Tens of thousands of cancers could be detected sooner each year thanks to ...
Pembrolizumab recommended as an adjuvant therapy for RCC across UK

Pembrolizumab recommended as an adjuvant therapy for RCC across UK

The Scottish Medical Consortium have recommended Pembrolizumab (Keytruda) as a monotherapy which is indicated for ...
Highlights from the ESMO Congress 2022

Highlights from the ESMO Congress 2022

We are delighted to share with you the report from The European Society of Medical Oncology (ESMO) congress 2022 ...